Stock listing

TSX:MDNA Medicenna Therapeutics Corp. Stock

Home listing (TSX) of Medicenna Therapeutics Corp.

Follow Medicenna Therapeutics Corp. into a list and get an email when it puts out news.

Share price · TSX:MDNA

$0.425 CAD -0.030 (-6.6%)

Close on Nov 2, 2026

Past year -71.7% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$0.425 – $0.435 CADNov 2, 2026
Volume
30,489 sharesNov 2, 2026
Market cap
$39.23M CADAt the close on Nov 2, 2026 · price × 92.30M shares outstanding
52-week range
$0.335 – $1.780 CADLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$21,088 CADMedian day 33,215 shares · 1 day with no trades · last 3 months, Aug 4, 2026 – Nov 2, 2026
Medicenna Therapeutics Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSX:MDNA · Home$0.425 CAD-0.030 (-6.6%)30,489$0.435$0.435$0.425$0.455Close on Nov 2, 2026
OTC:MDNAF$0.31 USD-0.001 (-0.4%)15,000$0.31$0.31$0.31$0.311Close on Oct 27, 2026

Daily closes

Last 3 months, Aug 4, 2026 – Nov 2, 2026 · TSX:MDNA · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.425-0.030-6.6%$0.435$0.435$0.42530,489
$0.455-0.025-5.2%$0.480$0.480$0.44595,904
$0.480+0.025+5.5%$0.455$0.480$0.455160,487
$0.455+0.025+5.8%$0.450$0.460$0.42091,671
$0.430+0.010+2.4%$0.420$0.445$0.42016,606
$0.420-0.005-1.2%$0.425$0.435$0.42042,680
$0.425+0.005+1.2%$0.420$0.445$0.42033,215
$0.420+0.010+2.4%$0.410$0.420$0.4107,600
$0.410+0.020+5.1%$0.390$0.425$0.38589,300
$0.390-0.020-4.9%$0.390$0.395$0.38553,500
$0.410-0.040-8.9%$0.450$0.450$0.38596,800
$0.450+0.010+2.3%$0.440$0.450$0.44020,000
$0.4400.0000.0%$0.445$0.445$0.44010,700
$0.440+0.005+1.1%$0.445$0.445$0.4258,800
$0.4350.0000.0%$0.450$0.460$0.43594,400
$0.435-0.010-2.2%$0.435$0.435$0.4303,000
$0.445-0.005-1.1%$0.450$0.460$0.43044,700
$0.450+0.015+3.4%$0.435$0.450$0.43523,800
$0.435+0.025+6.1%$0.400$0.470$0.395325,400
$0.410+0.025+6.5%$0.385$0.425$0.38515,000
$0.385-0.005-1.3%$0.400$0.400$0.38531,400
$0.390+0.005+1.3%$0.380$0.390$0.37020,100
$0.385-0.010-2.5%$0.385$0.400$0.38082,500
$0.3950.0000.0%$0.390$0.400$0.39054,200
$0.395-0.010-2.5%$0.405$0.405$0.3956,800
$0.4050.0000.0%$0.405$0.405$0.4050
$0.4050.0000.0%$0.405$0.410$0.4051,500
$0.405-0.005-1.2%$0.400$0.405$0.4001,800
$0.410-0.015-3.5%$0.415$0.415$0.41034,300
$0.4250.0000.0%$0.425$0.425$0.4251,500
$0.425+0.020+4.9%$0.415$0.430$0.41039,700
$0.405+0.005+1.3%$0.410$0.410$0.37049,700
$0.4000.0000.0%$0.395$0.400$0.38080,700
$0.400-0.020-4.8%$0.410$0.410$0.40047,300
$0.420+0.005+1.2%$0.430$0.430$0.4107,300
$0.415-0.005-1.2%$0.415$0.420$0.41024,900
$0.420-0.010-2.3%$0.430$0.430$0.42029,400
$0.430-0.030-6.5%$0.450$0.450$0.42584,600
$0.460-0.010-2.1%$0.470$0.470$0.45016,300
$0.4700.0000.0%$0.475$0.475$0.47014,500
$0.470+0.010+2.2%$0.465$0.480$0.46533,800
$0.460-0.010-2.1%$0.460$0.465$0.45061,200
$0.4700.0000.0%$0.475$0.480$0.46023,100
$0.470-0.005-1.1%$0.480$0.485$0.445127,800
$0.475+0.015+3.3%$0.475$0.480$0.4759,200
$0.460-0.010-2.1%$0.478$0.480$0.46026,100
$0.4700.0000.0%$0.480$0.490$0.47073,800
$0.470+0.035+8.0%$0.450$0.490$0.440101,500
$0.435+0.025+6.1%$0.415$0.455$0.41536,700
$0.410-0.005-1.2%$0.415$0.415$0.40026,300
$0.4150.0000.0%$0.435$0.435$0.40525,700
$0.415-0.020-4.6%$0.430$0.430$0.400152,400
$0.435-0.005-1.1%$0.440$0.440$0.42532,100
$0.440-0.020-4.3%$0.460$0.460$0.44044,900
$0.460+0.060+15.0%$0.410$0.460$0.410125,900
$0.400-0.005-1.2%$0.415$0.435$0.40064,000
$0.405+0.005+1.3%$0.405$0.410$0.40011,500
$0.400+0.005+1.3%$0.400$0.400$0.3957,100
$0.395+0.020+5.3%$0.390$0.395$0.38027,400
$0.375-0.015-3.8%$0.390$0.390$0.37521,400
$0.390+0.010+2.6%$0.400$0.400$0.37541,400
$0.380+0.020+5.6%$0.375$0.395$0.36070,800
$0.3600.0000.0%$0.365$0.370$0.33549,800
Ticker
TSX:MDNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TSX
Currency
CAD

What changed lately

Latest news

Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease

Oct 26, 2026

Closed $0.42 (-1.2%) on Oct 26, 2026

Medicenna to Present Preclinical Data on Its CD122 Superantagonist MDNA209 at The Promises of Treg and Interleukin-2 Therapies Conference

Oct 22, 2026

Closed $0.42 (+2.4%) on Oct 22, 2026

Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026

Oct 5, 2026

Closed $0.41 (+6.5%) on Oct 5, 2026

Medicenna Announces Results of Annual General and Special Meeting of Shareholders

Oct 1, 2026

Closed $0.385 (-1.3%) on Oct 2, 2026

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Sep 24, 2026

Closed $0.405 (0.0%) on Sep 24, 2026

Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Sep 3, 2026

Closed $0.47 (+2.2%) on Sep 3, 2026

Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences

Aug 14, 2026

Closed $0.46 (+15.0%) on Aug 14, 2026

Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights

Jun 26, 2026

Closed $0.405 (-2.4%) on Jun 26, 2026

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

Jun 11, 2026

Closed $0.43 (+2.4%) on Jun 11, 2026

Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

Jun 3, 2026

Closed $0.455 (+8.3%) on Jun 3, 2026

All Medicenna Therapeutics Corp. news

Decks

Medicenna Therapeutics Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
28 in the last 12 months · 143 in all · newest Oct 26, 2026 · oldest 2017
Decks
5 decks · latest September 2026

Where Medicenna Therapeutics Corp. is listed

ListingExchangeCountryCurrency
TSX:MDNA · Home listing · This pageTSXCanadaCAD
OTC:MDNAFOTCUnited StatesUSD
Cboe Canada:MDNACboe CanadaCanadaCAD

Log in to ask 6ix AI your own questions about Medicenna Therapeutics Corp.